HighLight Capital Joins $10M Round In Chinese Innovative Drug Developer Ennovabio

Login to View

Chinese innovative drug developer Ennovabio has raised a US$10 million pre-A round from healthcare-focused venture capital firm HighLight Capital, a firm founded by former CDH Investments partner Wang Hui. Another Chinese investment firm Zhangkelingyi also participated.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription